Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on natural killer cell activity in patients undergoing surgery for lung cancer
TCTR20180309001Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine in bronchial carcinoma, sponsored by Chulalongkorn University. Primary endpoint: Natural killer cell activity. Started Sep 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on TCTR20180309001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180309001.